A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Discover why heartburn intensifies the moment you lie down at night, plus 7 tested remedies to help you sleep comfortably without that burning chest pain.

Lucid Diagnostics Inc.�(Nasdaq: LUCD)�("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, a ...

While several effective treatment options for AFib exist, current evidence strongly suggests that pulsed field ablation (PFA) ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that by 2040, there will be approximately 957,000 new cases of esophageal cancer ...

A team of experts led by Northwestern Medicine investigators has developed a standardized approach that will improve the measurement of esophageal function to better diagnose upper gastrointestinal ...

Study confirms clinical utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy ... study-of-esoguard-esophageal-precancer-testing ...

May reveals what caused an esophagus injury that kept him sidelined ... One would assume that a 25-year-old pitcher who has an upper-90s heater would most likely face an IL stint due to arm ...